Plain-English translation of NCT07046494 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a new medication called can help treat manic episodes in people with bipolar I disorder. Researchers want to see if the medication works better than a placebo (an inactive pill) and how safe it is. This is an early-stage study designed to gather proof that the treatment shows promise.
Manic episodes can be severe and disruptive, and current treatment options don't work equally well for everyone. This study is exploring whether this medication offers a new, effective option for managing acute mania in bipolar I disorder.
You likely qualify if…
You likely don't qualify if…
You would stay in a hospital or inpatient clinic for 3 weeks. During that time, you would receive either or a placebo (an inactive pill) — neither you nor the researchers will know which one you're getting. The study team will monitor you regularly, check your symptoms, and watch for any side effects to determine whether the medication is safe and effective.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States